Stocksigma LogoStocksigma Logo

API Holdings Directly Absorbs 51.02% Stake in Thyrocare Following Docon Amalgamation

API Holdings has completed its amalgamation with Docon Technologies following NCLT Mumbai approval on 31st Aug'26 and RoC filing on 3rd Sep'26

API Holdings Directly Absorbs 51.02% Stake in Thyrocare Following Docon Amalgamation

Thyrocare Technologies Ltd 路 Others (Uncategorized) 路 04 Sept 2026, 10:00 pm

API Holdings Directly Absorbs 51.02% Stake in Thyrocare Following Docon Amalgamation API Holdings has completed its amalgamation with Docon Technologies following NCLT Mumbai approval on 31st Aug'26 and RoC filing on 3rd Sep'26. Effective 3rd Sep'26, Docon stands merged into API Holdings, resulting in the direct transmission and vesting of Docon's entire holding of 8,12,00,000 equity shares (51.02% stake) in Thyrocare Technologies to API Holdings. The transaction was executed under SEBI Takeover Regulation 10(1)(d)(iii) exemptions, leaving the overall promoter and promoter group aggregate shareholding in Thyrocare unchanged.

Original exchange filing (PDF)

More announcements from Thyrocare Technologies Ltd

All Thyrocare Technologies Ltd announcements